{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:06:09Z","timestamp":1788570369526,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":314,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["F31 AI122592"],"award-info":[{"award-number":["F31 AI122592"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["GRFP 2015214731"],"award-info":[{"award-number":["GRFP 2015214731"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Koch Institute","award":["1369\u2013341"],"award-info":[{"award-number":["1369\u2013341"]}]},{"DOI":"10.13039\/100013114","name":"Broad Institute","doi-asserted-by":"publisher","award":["Next Gen Fund"],"award-info":[{"award-number":["Next Gen Fund"]}],"id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1074\/mcp.ra119.001702","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T22:55:16Z","timestamp":1569538516000},"page":"2388-2400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry"],"prefix":"10.1016","volume":"18","author":[{"given":"Eric Vallabh","family":"Minikel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Vallabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Hartigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Reidenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri G.","family":"Safar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA119.001702_bib1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001702_bib2","doi-asserted-by":"crossref","first-page":"131175","DOI":"10.1172\/jci.insight.131175","article-title":"Antisense oligonucleotides extend survival of prion-infected mice","volume":"5","author":"Raymond","year":"2019","journal-title":"JCI Insight"},{"key":"10.1074\/mcp.RA119.001702_bib3","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1073\/pnas.1901947116","article-title":"Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development","volume":"116","author":"Vallabh","year":"2019","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1074\/mcp.RA119.001702_bib4","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Exome Aggregation Consortium (ExAC). Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/mcp.RA119.001702_bib5","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"},{"key":"10.1074\/mcp.RA119.001702_bib6","article-title":"Antisense oligonucleotides for the prevention of genetic prion disease","author":"Vallabh","year":"2019","journal-title":"PhD dissertation, Harvard University, Cambridge, MA"},{"key":"10.1074\/mcp.RA119.001702_bib7","article-title":"Food, U. S., Drug Administration. Critical Path Innovation Meeting: Genetic Prion Disease.","year":"2017","journal-title":"Requestor: Broad Institute"},{"key":"10.1074\/mcp.RA119.001702_bib8","first-page":"15","article-title":"Proteolytic processing of the prion protein in health and disease","volume":"1","author":"Altmeppen","year":"2012","journal-title":"Am. J. Neurodegener. Dis"},{"key":"10.1074\/mcp.RA119.001702_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-018-0248-6","article-title":"Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein","volume":"13","author":"Linsenmeier","year":"2018","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/mcp.RA119.001702_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0006-291X(05)80038-5","article-title":"A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies","volume":"184","author":"Tagliavini","year":"1992","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.RA119.001702_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/j.1460-9568.2010.07224.x","article-title":"Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease","volume":"31","author":"Schmitz","year":"2010","journal-title":"Eur. J. Neurosci"},{"key":"10.1074\/mcp.RA119.001702_bib12","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","article-title":"Truncated forms of the human prion protein in normal brain and in prion diseases","volume":"270","author":"Chen","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib13","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1073\/pnas.0308413101","article-title":"Cells release prions in association with exosomes","volume":"101","author":"Fevrier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001702_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-2009-1110","article-title":"Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders","volume":"17","author":"Meyne","year":"2009","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/mcp.RA119.001702_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1074\/mcp.RA119.001702_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3233\/JAD-160740","article-title":"Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and A\u03b242 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants","volume":"55","author":"Abu Rumeileh","year":"2017","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/mcp.RA119.001702_bib17","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s12035-018-1251-1","article-title":"Cerebrospinal fluid total prion protein in the spectrum of prion diseases","volume":"56","author":"Villar-Piqu\u00e9","year":"2018","journal-title":"Mol. Neurobiol"},{"key":"10.1074\/mcp.RA119.001702_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64705-0","article-title":"The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases","volume":"156","author":"Schulz-Schaeffer","year":"2000","journal-title":"Am. J. Pathol"},{"key":"10.1074\/mcp.RA119.001702_bib19","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1099\/vir.0.80947-0","article-title":"Prion clearance in bigenic mice","volume":"86","author":"Safar","year":"2005","journal-title":"J. Gen. Virol"},{"key":"10.1074\/mcp.RA119.001702_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature11058","article-title":"Sustained translational repression by eIF2\u03b1-P mediates prion neurodegeneration","volume":"485","author":"Moreno","year":"2012","journal-title":"Nature"},{"key":"10.1074\/mcp.RA119.001702_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1074\/mcp.RA119.001702_bib22","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/jvi.65.12.6597-6603.1991","article-title":"N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state","volume":"65","author":"Caughey","year":"1991","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA119.001702_bib23","first-page":"3552","article-title":"Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane","volume":"126","author":"Goold","year":"2013","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.RA119.001702_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI72241","article-title":"Prion disease tempo determined by host-dependent substrate reduction","volume":"124","author":"Mays","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1074\/mcp.RA119.001702_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrP(Sc) molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat. Med"},{"key":"10.1074\/mcp.RA119.001702_bib26","doi-asserted-by":"crossref","first-page":"e1002382","DOI":"10.1371\/journal.ppat.1002382","article-title":"Protease-resistant prions selectively decrease Shadoo protein","volume":"7","author":"Watts","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.RA119.001702_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib28","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1212\/WNL.0000000000005860","article-title":"Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance","volume":"91","author":"Hermann","year":"2018","journal-title":"Neurology"},{"key":"10.1074\/mcp.RA119.001702_bib29","doi-asserted-by":"crossref","first-page":"e02451","DOI":"10.1128\/mBio.02451-14","article-title":"Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid","volume":"6","author":"Orr\u00fa","year":"2015","journal-title":"mBio"},{"key":"10.1074\/mcp.RA119.001702_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02780662","article-title":"129\/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal","volume":"8","author":"Manson","year":"1994","journal-title":"Mol. Neurobiol"},{"key":"10.1074\/mcp.RA119.001702_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2013.02.004","article-title":"Lack of influence of prion protein gene expression on kainate-induced seizures in mice: studies using congenic, coisogenic and transgenic strains","volume":"238","author":"Striebel","year":"2013","journal-title":"Neuroscience"},{"key":"10.1074\/mcp.RA119.001702_bib32","doi-asserted-by":"crossref","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.RA119.001702_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-7244-9_14","article-title":"RT-QuIC assays for prion disease detection and diagnostics","volume":"1658","author":"Orr\u00f9","year":"2017","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/mcp.RA119.001702_bib34","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"The UniProt Consortium. UniProt: the universal protein knowledgebase","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001702_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pro.3290","article-title":"Clustal Omega for making accurate alignments of many protein sequences","volume":"27","author":"Sievers","year":"2018","journal-title":"Protein Sci. Publ. Protein Soc"},{"key":"10.1074\/mcp.RA119.001702_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-3524-6_9","article-title":"Multiplexed immunoaffinity enrichment of peptides with anti-peptide antibodies and quantification by stable isotope dilution multiple reaction monitoring mass spectrometry","volume":"1410","author":"Kuhn","year":"2016","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/mcp.RA119.001702_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1373\/clinchem.2015.250563","article-title":"Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays","volume":"62","author":"Hoofnagle","year":"2016","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib38","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.013854","article-title":"Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma","volume":"11","author":"Kuhn","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib39","doi-asserted-by":"crossref","first-page":"e1005416","DOI":"10.1371\/journal.ppat.1005416","article-title":"The distribution of prion protein allotypes differs between sporadic and iatrogenic Creutzfeldt-Jakob disease patients","volume":"12","author":"Moore","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.RA119.001702_bib40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbapap.2018.08.004","article-title":"Processing of high-titer prions for mass spectrometry inactivates prion infectivity","volume":"1866","author":"Moore","year":"2018","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib41","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc"},{"key":"10.1074\/mcp.RA119.001702_bib42","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1093\/bioinformatics\/btu148","article-title":"A framework for installable external tools in Skyline","volume":"30","author":"Broudy","year":"2014","journal-title":"Bioinforma. Oxf. Engl"},{"key":"10.1074\/mcp.RA119.001702_bib43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M700354-MCP200","article-title":"Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution","volume":"6","author":"Keshishian","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib44","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1373\/clinchem.2009.123935","article-title":"Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry","volume":"55","author":"Kuhn","year":"2009","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib45","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1074\/mcp.M114.047050","article-title":"Large-scale interlaboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma","volume":"14","author":"Abbatiello","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib46","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/acs.analchem.5b00331","article-title":"Quantitative performance of internal standard platforms for absolute protein quantification using multiple reaction monitoring-mass spectrometry","volume":"87","author":"Scott","year":"2015","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib47","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1074\/mcp.M900140-MCP200","article-title":"Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution","volume":"8","author":"Keshishian","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nbt.1524","article-title":"Prediction of high-responding peptides for targeted protein assays by mass spectrometry","volume":"27","author":"Fusaro","year":"2009","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.RA119.001702_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-6-36","article-title":"Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo","volume":"6","author":"Altmeppen","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/mcp.RA119.001702_bib50","doi-asserted-by":"crossref","first-page":"22590","DOI":"10.1074\/jbc.M109.032599","article-title":"Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein","volume":"284","author":"Taylor","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib51","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1074\/mcp.M600225-MCP200","article-title":"The proteomics of N-terminal methionine cleavage","volume":"5","author":"Frottin","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11095-005-9045-3","article-title":"Fit-for-purpose method development and validation for successful biomarker measurement","volume":"23","author":"Lee","year":"2006","journal-title":"Pharm. Res"},{"key":"10.1074\/mcp.RA119.001702_bib53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1373\/clinchem.2014.224840","article-title":"From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry","volume":"60","author":"Grant","year":"2014","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib54","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/pmic.200300670","article-title":"Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards","volume":"4","author":"Kuhn","year":"2004","journal-title":"Proteomics"},{"key":"10.1074\/mcp.RA119.001702_bib55","article-title":"Prion Alliance sponsors MGH research study","author":"Vallabh","year":"2017","journal-title":"PrionAlliance.org"},{"key":"10.1074\/mcp.RA119.001702_bib56","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.RA119.001702_bib57","doi-asserted-by":"crossref","first-page":"e76523","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PloS One"},{"key":"10.1074\/mcp.RA119.001702_bib58","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"10.1074\/mcp.RA119.001702_bib59","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1373\/clinchem.2017.278267","article-title":"Cerebrospinal fluid total protein reference intervals derived from 20 years of patient data","volume":"63","author":"McCudden","year":"2017","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib60","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1073\/pnas.90.7.2793","article-title":"Attempts to restore scrapie prion infectivity after exposure to protein denaturants","volume":"90","author":"Prusiner","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.RA119.001702_bib61","doi-asserted-by":"crossref","first-page":"e1002242","DOI":"10.1371\/journal.ppat.1002242","article-title":"Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate","volume":"7","author":"Kim","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.RA119.001702_bib62","doi-asserted-by":"crossref","first-page":"e1002835","DOI":"10.1371\/journal.ppat.1002835","article-title":"Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C)","volume":"8","author":"Kim","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.RA119.001702_bib63","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/JVI.00144-16","article-title":"Analysis of conformational stability of abnormal prion protein aggregates across the spectrum of Creutzfeldt-Jakob disease prions","volume":"90","author":"Cescatti","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/mcp.RA119.001702_bib64","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1016\/S0021-9258(20)79739-5","article-title":"Urea and guanidine hydrochloride denaturation of ribonuclease, lysozyme, alpha-chymotrypsin, and beta-lactoglobulin","volume":"249","author":"Greene","year":"1974","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001702_bib65","first-page":"12","article-title":"Serum thyroglobulin: a model of immunoassay imperfection","volume":"8","author":"Hoofnagle","year":"2006","journal-title":"Clin Lab Int"},{"key":"10.1074\/mcp.RA119.001702_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nmeth.3002","article-title":"CPTAC Assay Portal: a repository of targeted proteomic assays","volume":"11","author":"Whiteaker","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.RA119.001702_bib67","first-page":"1239","article-title":"Food and Drug Administration. Bioanalytical Method Validation","year":"2018","journal-title":"Guidance for Industry"},{"key":"10.1074\/mcp.RA119.001702_bib68","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1074\/mcp.RA117.000543","article-title":"Panorama public: a public repository for quantitative data sets processed in Skyline","volume":"17","author":"Sharma","year":"2018","journal-title":"Mol. Cell. Proteomics MCP"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620316443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620316443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA119.001702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:30:11Z","timestamp":1761525011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620316443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1535947620316443"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra119.001702","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/591487","asserted-by":"object"}]},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA119.001702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Minikel et al.","name":"copyright","label":"Copyright"}]}}